Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX
Rumors Preceded Broder’s Move
NCI “Leadership Vacuum” Deepened?
“I’m Not Bummed Out By This” – Broder
IVAX And It’s Portfolio
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center
- Tweaking the existing systems is not the answer to drug shortages